Research on Malignancies in AIDS and Acquired Immune Suppression

The summary for the Research on Malignancies in AIDS and Acquired Immune Suppression grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Research on Malignancies in AIDS and Acquired Immune Suppression: The purpose of this initiative is to stimulate research that will improve our understanding of the biological basis of development and progression of cancer in the context of Human Immunodeficiency Virus (HIV) infection and Acquired Immune Deficiency Syndrome (AIDS) or acquired immune suppression not associated with HIV infection such as organ transplantation. The NCI and NIDCR seek to encourage novel approaches to discovery and preclinical development of novel therapeutic agents and biomarkers for early diagnosis and monitoring of disease progression. Molecular epidemiologic studies of the role of chronic latent viruses and their interaction with one another or with environmental factors in the context of acquired immune suppression or HIV infection leading to the development of tumors or lesions with oncogenic potential are also of interest. This PA will use the NIH exploratory/development (R21) award mechanism and the NIH investigator-initiated research project grants (R0! 1) award mechanism. Please see the link at http://grants.nih.gov/grants/guide/notice-files/NOT-OD-03-041.html for the NIH policy on submitting revised applications . It is anticipated that 2 million in total costs will be awarded in the first year to fund 8 12 applications. Application material and instructions are available at http://grants.nih.gov/grants/funding/phs398/phs398.html in an interactive format.
Federal Grant Title: Research on Malignancies in AIDS and Acquired Immune Suppression
Federal Agency Name: National Institutes of Health
Grant Categories: Health Education
Type of Opportunity: Discretionary
Funding Opportunity Number: PA-04-157
Type of Funding: Grant
CFDA Numbers: 93.12193.393
CFDA Descriptions: Oral Diseases and Disorders Research 93.393 Cancer Cause and Prevention Research
Current Application Deadline: No deadline provided
Original Application Deadline: Multiple Receipt Dates - See Link to Full Announce
Posted Date: Sep 30, 2004
Creation Date: Dec 15, 2006
Archive Date: Feb 03, 2007
Total Program Funding: $2,000,000
Maximum Federal Grant Award: $200,000
Minimum Federal Grant Award:
Expected Number of Awards: 8
Cost Sharing or Matching: 93.396 -- Cancer Biology Research
Applicants Eligible for this Grant
Public and State controlled institutions of higher education Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education Independent school districts County governments Small businesses Public housing authorities/Indian housing authorities Native American tribal organizations (other than Federally recognized tribal governments) City or township governments Others (see text field entitled "Additional Information on Eligibility" for clarification) For profit organizations other than small businesses Native American tribal governments (Federally recognized) State governments Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Special district governments
Additional Information on Eligibility
Eligible agencies of the Federal Government are eligible to apply. Foreign institutions are eligible to apply.
Link to Full Grant Announcement
Information not provided
Grant Announcement Contact
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [email protected] NIH OER Webmaster